inner-banner

ANZICS CTG Current Active Research

ANZICS CTG Current Active Research

ANZICS CTG Current Research

You can select the short title below for more information on the study.

Currently recruiting (24)
Study number Short name Study title
CTG1718-04 ARISE FLUIDS

Australasian resuscitation in sepsis evaluation: fluids

CTG2324-03 BEST-DKA

Balanced multi-electrolyte solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis

CTG1718-05 BONANZA-GT

Brain oxygen neuromonitoring in Australia and New Zealand assessment trial

CTG2021-05 Bone Zone

Bone Loss Prevention with Zoledronic Acid or Denosumab in Critically Ill Women

CTG2223-01 CALIPSO

The Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study: multicentre, adaptive, double-blind, three-arm, placebo-controlled, noninferiority trial examining antimicrobial prophylaxis duration in cardiac surgery

CTG 2021-07 CLiP II NZ

CLip II NZ - A phase III multicentre blinded randomised controlled clinical non-inferiority trial of cryopreserved platelets vs. conventional liquid-stored platelets for the management of post-surgical bleeding. The cryopreserved vs. liquid platelets trial

CTG2223-04 DRIVE RCT

DRIVing PrEssure Limited Ventilation in Hypoxemic Respiratory Failure–Randomised Control Trial

CTG2324-01 DRIVE RCT-NZ

DRIVing PrEssure Limited Ventilation in Hypoxemic Respiratory Failure–Randomised Control Trial

CTG1617-05 EPO TRAUMA

A prospective, multicentre, randomised, doubleblind placebo controlled, stratified phase III trial of epoetin alfa vs. placebo in critically ill trauma patients

CTG1819-03 The EXCEL Study

A comprehensive national registry on the treatment and outcomes of patients requiring ECMO

CTG2021-04 FEISTY II

Fibrinogen Early In Severe Trauma studY II

CTG2425-01 FLASH

FLudrocortisone administration in Aneurysmal Subarachnoid Haemorrhage The FLASH Trial

CTG2324-04 ICU-RESOLVE-D

Digital Peer Support for ICU Survivors: icuRESOLVE-D (Intensive Care Unit REcovery Solutions cO-Led through surVivor Engagement Digital) Study

CTG2021-08 LOGICAL

Low OxyGen Intervention for Cardiac Arrest injury Limitation

CTG1920-01 Mega-ROX

The mega randomised registry trial comparing conservative vs. liberal oxygenation targets

CTG2122-02 NEPTUNE

neT ultrafiltration Prescription and Targeting versus Usual NEt ultrafiltration during continuous renal replacement therapy

CTG2223-02 PREVENTS-AKI

PREVENTion with SGLT-2 inhibition of Acute Kidney Injury in intensive care

CTG2122-04 ProBeFluid-KRT

Pilot open-label trial of protocol-based fluid removal vs usual care in critically ill patients on kidney replacement therapy

CTG1415-02 REMAP-CAP

Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia

CTG2223-03 SODA-BIC RCT

SODium BICarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC): A multicentre, randomised, double-blind clinical trial

CTG2021-02 SPICE-IV

Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients: A Prospective, Multi-centre, Double-Blind, Randomized Controlled Trial.

CTG1516‐01 SPRINT‐SARI

Short Period Incidence Study of Severe Acute Respiratory Infection

CTG2324-02 STEPCARE

Sedation, Temperature and Pressure after Cardiac Arrest and Resuscitation - The STEPCARE Trial

CTG2324-05 T4P

T4P - The Threshold for Platelets study: a prospective randomised trial to define the platelet count below which critically ill patients should receive a platelet transfusion prior to an invasive procedure